文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

目前不明原发灶癌症的发病率正在下降。

The currently declining incidence of cancer of unknown primary.

机构信息

Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; Department of Hematology-Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.

University of Ioannina, Ioannina, Greece.

出版信息

Cancer Epidemiol. 2019 Aug;61:139-141. doi: 10.1016/j.canep.2019.06.006. Epub 2019 Jun 26.


DOI:10.1016/j.canep.2019.06.006
PMID:31254795
Abstract

Cancer of unknown primary (CUP) is a heterogeneous group of metastatic cancers for which a primary tumor cannot be identified after a standardized work-up. The biology of CUP has not been fully elucidated and epidemiologic data may be helpful in this regard. The variations in the incidence-rate over time and between countries reflect changes in the risk factors for CUP, incidence trends of the primary tumors that potentially contribute to the burden of CUP and changes in the diagnostic technologies and practice. CUP accounted for 3-5% of cancers in the historical series but its incidence seems to decline in the recent publications. This paper reviews the published cancer-registry studies in order to identify and understand the variations in the incidence-rates of CUP.

摘要

原发灶不明的癌症(CUP)是一组异质性转移性癌症,经过标准化检查后仍无法确定原发性肿瘤。CUP 的生物学特性尚未完全阐明,而流行病学数据在这方面可能会有所帮助。发病率随时间和国家的变化反映了 CUP 危险因素的变化、可能导致 CUP 负担的原发性肿瘤的发病趋势以及诊断技术和实践的变化。在历史系列中,CUP 占癌症的 3-5%,但其发病率在最近的出版物中似乎有所下降。本文综述了已发表的癌症登记研究,以确定和理解 CUP 发病率的变化。

相似文献

[1]
The currently declining incidence of cancer of unknown primary.

Cancer Epidemiol. 2019-6-26

[2]
Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.

Eur J Cancer Prev. 2012-5

[3]
Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.

Cancer Med. 2018-7-17

[4]
Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.

Eur J Cancer Prev. 2012-11

[5]
Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.

Aust N Z J Public Health. 2008-8

[6]
An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data.

Cancer Epidemiol. 2014-6-11

[7]
Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.

Sci Rep. 2016-3-24

[8]
Cancer of unknown primary: time trends in incidence, United States.

Cancer Causes Control. 2014-6

[9]
Cancer of unknown primary is associated with diabetes.

Eur J Cancer Prev. 2016-5

[10]
Incidence of cancers of unknown primary origin in India and their trends during 1986-2014: A joinpoint regression analysis.

Indian J Cancer. 2022

引用本文的文献

[1]
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.

Cancer Res Commun. 2025-9-1

[2]
CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary.

ESMO Open. 2025-7-23

[3]
Cancer of Unknown Primary: A Case Report on the Recognition of Its Clinical Entity and Standard of Care Management.

Cureus. 2025-6-20

[4]
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Nat Commun. 2025-5-20

[5]
Skeletal Muscle Density as a Predictor of Prognosis and Physical Reserve in Patients with Cancer of Unknown Primary.

J Clin Med. 2025-4-24

[6]
Impact of whole genome sequencing on the care pathway for patients with cancer of unknown primary.

ESMO Open. 2025-5

[7]
Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine.

MedComm (2020). 2025-4-16

[8]
Aggressive Squamous Cell Carcinoma of Unknown Primary: Isolated Inguinal Metastasis and Uncommon Progression.

Am J Case Rep. 2025-4-15

[9]
Case Report: Personalized diagnosis and treatment strategies for three cases of cancer of unknown primary based on molecular testing techniques.

Front Oncol. 2025-3-28

[10]
Clinical characteristics and survival analysis of cancer of unknown primary.

Oncol Lett. 2025-2-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索